Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer

  • STATUS
    Enrolling By Invitation
  • participants needed
    160
Send
Updated on 19 February 2024

Summary

We are inviting you to take part in a research study. Research is a way of gaining new knowledge. A person who participates in a research study is called a “participant.” This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer. Palliative care is a medical specialty focused on lessening (or “palliating”) patients’ symptoms and helping patients and their families cope with a serious illness. It is expected that about 480 people will take part in this research study. This study will take place at the Massachusetts General Hospital Cancer Center, the Hospital of the University of Pennsylvania, and Duke Cancer Center. The HUP site plans to enroll 160 participants. An institution that is supporting a research study either by giving money or supplying something that is important for the research is called the “sponsor.” The sponsor of this study is Massachusetts General Hospital (MGH), which is supporting this research study by providing funding.

Details
Condition cancer, palliative care
Age 18years - 90years
Clinical Study IdentifierTX6318
Last Modified on19 February 2024

Eligibility

If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.